These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8114320)

  • 21. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
    Shindo M; Arai K; Sokawa Y; Okuno T
    Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
    Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK
    Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
    Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
    J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
    Davis GL; Lau JY
    J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.
    Knolle PA; Kremp S; Höhler T; Krummenauer F; Schirmacher P; Gerken G
    J Viral Hepat; 1998 Nov; 5(6):399-406. PubMed ID: 9857349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha interferon treatment in chronic hepatitis C.
    Idéo G; Bellobuono A; Mondazzi L; Tempini S; Bellati G; Idéo GM; Silini E
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S167-73. PubMed ID: 8730501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
    Kondo M; Tanaka K; Ikeda M; Arata S; Saito S; Sakaguchi T; Morimoto M; Fujii T; Mitsui K; Okazaki H; Hoshino M; Sekihara H
    J Gastroenterol Hepatol; 1996 Mar; 11(3):236-40. PubMed ID: 8742919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment.
    Taliani G; Badolato C; Lecce R; Poliandri G; Bozza A; Duca F; Pasquazzi C; Clementi C; Furlan C; De Bac C
    J Med Virol; 1995 Sep; 47(1):16-22. PubMed ID: 8551253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.
    Okuda M
    Gastroenterol Jpn; 1993 Aug; 28(4):535-40. PubMed ID: 8397131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
    Chan TM; Wu PC; Lau JY; Lok AS; Lai CL; Cheng IK
    Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
    Lau JY; Davis GL; Kniffen J; Qian KP; Urdea MS; Chan CS; Mizokami M; Neuwald PD; Wilber JC
    Lancet; 1993 Jun; 341(8859):1501-4. PubMed ID: 8099380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan.
    Yoshikawa M; Fukui H; Kojima H; Yoshiji H; Sakamoto T; Imazu H; Nakanani T; Matsumura Y; Kuriyama S; Yamao J
    J Gastroenterol; 1995 Jun; 30(3):367-71. PubMed ID: 7647904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
    Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
    Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy.
    Hino K; Okuda M; Konishi T; Ishiko H; Okita K
    Dig Dis Sci; 1995 Jan; 40(1):14-20. PubMed ID: 7821101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.
    Lau JY; Mizokami M; Ohno T; Diamond DA; Kniffen J; Davis GL
    Lancet; 1993 Nov; 342(8881):1208-9. PubMed ID: 7901531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.
    Clarysse C; Van den Eynde C; Nevens F; Portier C; Aelbrecht N; Fevery J; Yap SH
    Neth J Med; 1995 Dec; 47(6):265-71. PubMed ID: 8569931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.